Erlotinib

Strength: 25 mg, 100 mg, 150 mg

Dosage Form: Tablet

Description:

Erlotinib is a tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR), used mainly for non-small cell lung cancer and pancreatic cancer.

Key Features:

• Oral targeted therapy
• Effective in EGFR mutation-positive tumors
• Convenient once-daily dosing

Precautions:

May cause skin rash, diarrhea, and interstitial lung disease. Monitor liver function.